Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.68 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.68 |
| ▸ | ESR1 | P03372 | 4/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.44 |
| ▸ | PRKCI | P41743 | 1/20 | 0.40 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | CTRC | Q99895 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29719025 | 0.89 | GABRA1 (0.56) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL2475390 | 0.89 | GABRA1 (0.56) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL5676415 | 0.87 | GABRA1 (0.54) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL5196215 | 0.87 | PRKCI (0.57) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL16527810 | 0.85 | GABRA1 (0.59) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL24451093 | 0.84 | GABRA1 (0.52) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL17916374 | 0.84 | GABRA1 (0.52) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL4961265 | 0.83 | GABRA1 (0.56) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL8678918 | 0.83 | GABRA1 (0.50) | GABRA1GABRB2ESR1ESR2PRKCI | |
| SCHEMBL1174451 | 0.83 | CA2 (0.50) | GABRA1GABRB2ALOX15ALOX12HSPA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9212286-B2 | Methods and systems for coating a surface | ALLACCEM, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-8268381-B2 | Methods and systems for coating a medical device | ALLACCEM, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-8222239-B2 | quaternary ammonium compounds, conjugated to polymers, used as microbiocides | ALLACCEM, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-8188068-B2 | Bridged polycyclic compound based compositions for coating oral surfaces in pets | ALLACCEM, INC. (US) | 2012-05-29 | — | — | US | disclosed |
| US-8153617-B2 | Bridged polycyclic compound based compositions for coating oral surfaces in humans | ALLACCEM, INC. (US) | 2012-04-10 | — | — | US | disclosed |
| US-8153618-B2 | Bridged polycyclic compound based compositions for topical applications for pets | ALLACCEM, INC. (US) | 2012-04-10 | — | — | US | disclosed |
| US-8067403-B2 | Methods and systems for preparing an antimicrobial composition | ALLACCEM, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| US-8067402-B2 | Methods and systems for coating an oral surface | ALLACCEM, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| US-7939819-B2 | Circuit board, electro-optical device, and electric apparatus | SEIKO EPSON CORPORATION (JP) | 2011-05-10 | — | — | US | disclosed |
| US-7825403-B2 | Circuit board including a substrate with a recessed portion and manufacturing method thereof, electro-optical device and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2010-11-02 | — | — | US | disclosed |
| US-20080020127-A1 | Methods and systems for coating a medical device | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20070221958-A1 | CIRCUIT BOARD AND MANUFACTURING METHOD THEREOF, ELECTRO-OPTICAL DEVICE, AND ELECTRONIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2007-09-27 | — | — | US | disclosed |
| US-20070215377-A1 | CIRCUIT BOARD, ELECTRO-OPTICAL DEVICE, AND ELECTRIC APPARATUS | SEIKO EPSON CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070202342-A1 | Applying to an oral surface (teeth or gums)one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning; dentistry; bonding agents, resin cements, sealants | ALLACCEM, INC. | 2007-08-30 | — | — | US | disclosed |
| US-7067450-B2 | Soluble late transition metal catalysts for olefin oligomerizations III | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-06-27 | — | — | US | disclosed |
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | ZHAO BAIYI | 2006-02-16 | — | — | US | disclosed |
| EP-1620447-A1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | Exxonmobil Chemical Patents Inc. (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20040044150-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-03-04 | — | — | US | disclosed |
| WO-2003102006-A1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | COMT, CD69, SPR | GABRA1 3633/4885GABRB2 3569/4885ESR1 26/4885 |
| US-20080021212-A1 | Methods and systems for preparing an antimicrobial composition | DNMT1, TET2, POLR1C | GABRA1 3855/4885GABRB2 4175/4885ESR1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.